# OnCo record nerviano-medical-sciences (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/nerviano-medical-sciences/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "nerviano-medical-sciences" ;
  schema:name "Nerviano Medical Sciences"@en ;
  schema:alternateName "Nerviano Medical Sciences Ltd."@en, "Nerviano Medical Sciences (Shanghai) Ltd."@en, "Nerviano Medical Sciences S.r.l."@en, "NMS"@en ;
  schema:description "Nerviano Medical Sciences is an Italian drug-discovery company founded in 2004 in Nerviano, near Milan, that leads two cancer trials in OnCo: the PARP1-selective inhibitor atamparib in advanced solid tumours and NMS-03305293 with temozolomide in recurrent glioblastoma."@en ;
  schema:url <https://onco.cc/companies/nerviano-medical-sciences/>, <http://www.nervianoms.com/en/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <http://www.nervianoms.com/en/>, <https://www.wikidata.org/wiki/Q30280722>, <https://clinicaltrials.gov/search?lead=Nerviano%20Medical%20Sciences> ;
  onco:tag "ctgov-sponsor", "wave5-sponsor" ;
  schema:addressCountry "IT" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/glioblastoma/> ;
  onco:drugs <https://onco.cc/drugs/temozolomide/> ;
  onco:trials <https://onco.cc/trials/nct07374419/>, <https://onco.cc/trials/nct04910022/> .